Human lymphocytes can be broadly separated into B-or T-cells (22) . Patients with a selective loss of B-lymphocytes suffer from recurrent extracellular bacterial infections, whereas individuals with a selective loss of Tlymphocytes may suffer from recurrent viral infections (8) . In addition, patients with viral infections commonly show an acute, transient diminution in cellular immune responses, which suggests impaired T-lymphocyte function (15) . These observations indicate that the response of the human lymphoid system to infection may vary with the type of infectious challenge. However, one report demonstrated no change in the number of circulating B-or Tlymphocytes in patients with bacterial and viral infections (1), whereas another reported that patients with infections had alterations in peripheral blood lymphocyte subpopulations (14) . The present studies were undertaken with a variety of systemic infections to clarify the peripheral blood lymphocyte response to infection in humans. This was accomplished by enumerating B-, T-, and virus-infectible lymphocytes during bacterial and viral infections.
MATERIALS AND METHODS

Subjects. Patients having infections caused by a
variety of bacterial or viral agents were studied. During the time of study they were hospitalized at Parkland Memorial Hospital or the Veterans Administration Hospital in Dallas, Tex. The duration of infection prior to study was estimated by historical information obtained from medical records.
Patients with bacterial infections (Table 1) were studied for a median of 10 days (range, 2 to 45 days) after the onset of illness. Their infections were predominantly caused by gram-positive pyogenic bacteria. Etiological organisms were identified by culture; the only exceptions were patients with typhoid and paratyphoid fever in whom etiology was serologically proven and patients with lung and brain abscesses in whom appropriate cultures were not performed. All patients with bacterial infections were being treated with antibacterial agents at the time of study. The mean patient age was 35 years (range, 13 to 79 years).
Patients with viral infections (Table 2) were studied a median of 8 days (range, 2 to 24 days) after the onset of illness. The viral agent was isolated from 4 patients and serologically identified from 12. The other 12 had a typical viral syndrome (e.g., hepatitis, mononucleosis), and no bacterial agent was isolated from repeated bacterial culture attempts. No patient was receiving antiviral chemotherapy during the time of study. The mean patient age was 29 years (range, 10 to 59 years).
Control subjects included 19 laboratory and hospital personnel and 21 patients who had been hospitalized with high-risk pregnancies as that resulted from hypertension. There were no differences in the numbers of peripheral blood cells between the personnel and pregnant hypertensive controls. The mean age of control subjects was 29 years (range, 16 to 43 years). The race and sex distributions of controls were similar to those for patients. Blood from controls was run in parallel with blood from pa- tients. Multiple studies were performed on some patients and controls. Blood collection, counting, and separation. A 14-ml quantity of venous blood was collected in ethylenediaminetetraacetic acid. Peripheral blood leukocyte counts were performed in a Neubauer chamber, and differential counts were done on 100 cells. The number of each cell type was determined by multiplying the total leukocyte counts by the differential proportion of each cell type. One part of blood was mixed with three parts of sterile isotonic saline. This mixture was layered over a 24:10 ratio of 9% Ficoll-33.9% Hypaque and centrifuged for 30 min at 600 x g (4). The cell suspension obtained was washed twice with minimum essential medium (MEM) and used for all assays. Morphologically it contained 85 to 95% lymphocytes.
B-lymphocyte assay. The suspension of lymphocytes was incubated at 37°C for 30 min with 50 ml of a 1:4 dilution of fluoresceinated goat antiserum in phosphate-buffered saline (pH 7.2), which is specific for human mu chains (Meloy Laboratories, Springfield, Va.), and ultracentrifuged prior to use. The antiserum was monospecific by gel radial immunodiffusion at a protein concentration of 10 mg/ml and contained 4 x 106 Ag offluorescein per mg ofprotein.
After incubation with the antiserum, cell suspensions were washed twice with phosphate-buffered saline, cleared of erythrocytes by adding 9.85% NH4CI-Tris buffer, pH 7.65, and then mounted on glass slides using nail polish-sealed cover slips. Two hundred cells were scored under code as positive or negative for membrane immunofluorescence. Bcells were quantitated by multiplication of the total lymphocyte count by the percentage of immunofluorescence-positive cells. In some preparations, latex particles were added prior to incubation to detect phagocytic cells that were consistently less than 15%. A negative control was performed with fluorescenated normal goat serum.
B-lymphocyte assay with incubation. Lymphocytes were collected and separated as above from five patients with three types of acute infections: pneumonococcal pneumonia, staphylococcal endocarditis (2), and hepatitis B antigen hepatitis (2) . B-lymphocytes were quantitated both before and after incubation in MEM at 37°C in 5% CO2 for 18 h.
T-lymphocyte assay. T-lymphocytes were quantitated in a smaller number of patients using the active sheep cell rosette assay. This assay was chosen since it may more accurately reflect T-lymphocyte function than the total sheep cell rosette assay (22 (3) . The cells were collected by centrifugation, washed twice with MEM containing 2% fetal calf serum (MEM-FCS), and then incubated with 0.2 ml of rabbit anti-vesicular stomatitis virus serum having a neutralizing antibody titer of 1:128 at 370C for 30 min to neutralize extracellular virus. After three additional washes with MEM-FCS, the button was resuspended in 1 ml of MEM-FCS, and 10-fold dilutions of cells in MEM-FCS were made. A 0.5-ml portion of each dilution containing 106, 105, 104, or 103 virus-infected lymphocytes was mixed with an equal volume of warmed 1.25% agarose in MEM-FCS (nutrient agar) and then layered over a monolayer of Vero cells. The final wash after incubation with neutralizing anti-vesicular stomatitis virus serum was processed in the same fashion to serve as a control for the absence of viable extracellular virus. After the agar had solidified, the plates were overlaid with 3 ml of nutrient agar and then incubated at 37°C for 48 h in a 5% CO2 atmosphere. At the end of incubation, monolayers were stained with 1.5 ml of 1:10,000 neutral red in nutrient agar, and monolayer plaques for each dilution of lymphocytes were counted. The results were expressed as the number of virus-infectible cells per 100,000 lymphocytes.
Statistics. The significance of the differences of means was estimated by the nonpaired t-test.
RESULTS
Blood counts. Peripheral blood leukocyte counts taken from 34 patients during bacterial infections, 28 patients during viral infections, and 40 controls are summarized in Table 3 . Both groups of patients had a greater number of circulating leukocytes compared to that for control subjects. The increased number of leukocytes reflected a neutrophilia in patients with bacterial infections but reflected a lym- B-lymphocytes with incubation. There was no difference in the number of B-cells from five patients measured before and after an 18-h incubation, indicating that fluorescein-positive cells were indeed B-lymphocytes (Table 4) .
T-lymphocytes. The percentages of peripheral blood rosette-forming cells in patients with bacterial infections and controls were similar to that for the controls (24%), but patients with viral infections had a significantly greater proportion of circulating, active rosette-forming cells (33%) compared to that for control subjects (Table 5) .
Virus-infectible lymphocytes. Patients with bacterial infections had greater numbers of circulating, virus-infectible lymphocytes than did DISCUSSION Our studies confirm time-honored observations that the peripheral blood neutrophil count is significantly elevated during bacterial infections (10, 19) but is less so during viral infections (6) . In contrast, lymphocytosis does not regularly accompany bacterial infections but has been extensively described during viral infections, especially infectious mononucleosis (18) . Transiently reduced lymphocyte counts have been demonstrated within the first week of experimental infectious hepatitis, but they are followed by a lymphocytosis that is more characteristic of viral infections (9) .
The analysis of peripheral blood lymphocyte subpopulations is an approach to understanding the immune response to infectious agents. Patients with bacterial infections had an increased number of circulating B-lymphocytes, whereas patients with viral infections did not. This agrees with observations by Niklasson and Williams (14) but not with those of Aiuti et al. (1) . Others have demonstrated an increase in peripheral blood B-lymphocytes during viral infections (5, 7, 16) . Most authors reporting Bcells during infections have not rigorously excluded cytophilic antibody which may result in an overestimation of the number of B-lymphocytes (11, 13) . To avoid this, we quantitated only lymphocytes having surface mu chains, which appears to more specifically mark B-cells (13) . In addition, overnight incubation of lymphocytes resulted in no diminution of mupositive cells, suggesting that these fluoresceinpositive lymphocytes did not have surface cytophilic antibody. An overestimation of B-lymphocytes due to cytophilic antibody had been demonstrated, particularly with gamma-positive cells (20, 21) . Patients with bacterial infections had a normal percentage of peripheral blood T-lymphocytes, whereas patients with viral infections had an increased percentage. This increase in T-cells in patients with viral infections was reflected in an elevation of the peripheral blood lymphocyte count. Others have documented elevated T-lymphocytes during specific viral infections (5, 7, 14, 17) . However, the proportion of peripheral blood lymphocytes estimated to be T-cells utilizing rosettes from nonimmune SRBCs has varied from 35 to 80% in controls (2) . We elected to use the "active" rosette test rather than "total" rosette tests because of the suggestion that the active test is a better reflection of T-cell competence (22) . Lower values obtained with this test, however, make any inferences about null cells impossible.
Patients with bacterial infections had a greater number of virus-infectible peripheral blood cells than controls or patients with viral infections. These cells may represent "activated" T-lymphocytes (3, 12) . The proportion of peripheral blood virus-infectible cells was so small that the increase in activated T-cells in patients with bacterial infections occurred in the face of normal total numbers of T-lymphocytes. Conversely, patients with viral infections had a normal number of virus-infectible cells in the face of elevated total numbers of Tlymphocytes.
Thus, these studies indicate a fundamental difference in the response of the human lymphoid system with different types of infectious agents. These findings are consistent with clinical observations that relate infectious diseases to B-and T-lymphocyte defects.
